ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,793Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 118

$778K Total Retail Price of All Prescriptions

Rank: 9 out of 118

462 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

5% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 10,977 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 64%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $170 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 552 501 1 8
FUROSEMIDE 500 494 2 7
LEVOTHYROXINE SODIUM 441 391 3 10
ATORVASTATIN CALCIUM 328 317 4 17
OMEPRAZOLE 302 289 5 11
WARFARIN SODIUM 288 277 6 15
METOPROLOL TARTRATE 277 277 7 16
AMLODIPINE BESYLATE 212 204 8 9
LISINOPRIL 202 193 9 12
HYDROCHLOROTHIAZIDE 195 195 10 20
PREDNISONE 182 179 11 4
LOSARTAN POTASSIUM 177 171 12 34
ADVAIR DISKUS 172 165 13 2
MIRTAZAPINE 152 152 14 43
PANTOPRAZOLE SODIUM 136 135 15 35
ESCITALOPRAM OXALATE 136 128 15 39
ATENOLOL 135 112 17 24
DIOVAN 135 124 17 32
TRAZODONE HCL 132 121 19 27
POTASSIUM CHLORIDE 131 131 20 29
CRESTOR 115 105 21 37
TAMSULOSIN HCL 108 101 22 40
GABAPENTIN 106 102 23 25
HYDROCODONE-ACETAMINOPHEN 105 105 S3 24 38
METFORMIN HCL 105 97 24 23
CITALOPRAM HBR 103 90 26 36
ALENDRONATE SODIUM 103 91 26 46
METOPROLOL SUCCINATE 102 81 28 26
SPIRIVA 101 93 29 1
ALLOPURINOL 99 98 30 50
CARVEDILOL 96 96 31 41
CLOPIDOGREL 96 84 31 61
CARBIDOPA-LEVODOPA 94 73 33 79
AZITHROMYCIN 90 88 34 14
DOXYCYCLINE HYCLATE 88 57 35 72
SERTRALINE HCL 84 81 36 33
SPIRONOLACTONE 83 80 37 75
ENALAPRIL MALEATE 83 72 37 78
LIPITOR 81 68 39 76
GLIPIZIDE ER 78 72 40 118
DONEPEZIL HCL 77 77 41 31
TERAZOSIN HCL 77 66 41 119
NEXIUM 76 70 43 28
GLIPIZIDE 72 67 44 58
TRAMADOL HCL 71 71 45 42
CIPROFLOXACIN HCL 70 63 46 87
GLIPIZIDE XL 69 69 47 128
ISOSORBIDE MONONITRATE ER 69 69 47 69
METFORMIN HCL ER 67 67 49 131
DIGOXIN 67 67 49 52
TRIAMTERENE-HCTZ 66 66 51 93
IPRATROPIUM-ALBUTEROL 65 59 52 60
LEXAPRO 64 62 53 91
PRAVASTATIN SODIUM 62 62 54 53
DIOVAN HCT 61 54 55 92
PLAVIX 61 56 55 73
NAMENDA 61 61 55 62
LANTUS 60 50 58 51
CYMBALTA 58 58 59 45
LEVOFLOXACIN 57 56 60 55
BENICAR 57 57 60 95
KLOR-CON M20 56 56 62 68
VENLAFAXINE HCL ER 56 51 62 146
EXELON 53 53 64 151
DOXAZOSIN MESYLATE 53 53 64 101
LIDODERM 52 52 66 77
LOSARTAN-HYDROCHLOROTHIAZIDE 52 40 66 102
COMBIVENT 52 52 66 19
PROPRANOLOL HCL 51 51 69 156
QUETIAPINE FUMARATE 51 51 69 44
SINGULAIR 50 38 71 6
LOVASTATIN 50 49 71 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.